Home/ Supplements/ Boswellia/ Min-Inflamm

Min-Inflamm

product on market Capsule Pharmax Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains ingredients like curcumin, ginger, and bromelain, which have moderate to strong evidence for reducing inflammation. Salicin and frankincense are also utilized for their potential anti-inflammatory properties. Overall, these components are supported by research for managing inflammatory responses.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Min-Inflamm
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Salicin
190 mg
190 mg
Market median: 450.0mg (254 products) 243 studies (A:0, B:100)
Market median: 375.0mg (171 products) 31 studies (A:1, B:14)
25 mg
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)
30 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews

Other Ingredients

Hypromellose Silica Vegetable Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended adult intake: Once capsule taken daily with a meal or as professionally directed.

Warnings & Precautions

Risk information: If you are pregnant or breastfeeding; if you are allergic to salicylates; if you have asthma, glucose-6-phosphate dehydrogenase deficiency or a bile duct obstruction, do not use.

Risk information: If you are pregnant or breastfeeding; if you are allergic to salicylates; if you have asthma, glucose-6-phosphate dehydrogenase deficiency or a bile duct obstruction, do not use.

If you are taking anti-inflammatory agents, antiplatelet medication, blood thinners or antibiotics or before having surgery; if you have gastrointestinal lesions/ ulcers, gallstones, excess stomach acid or severe liver or renal dysfunction, consult your healthcare practitioner prior to use.

If symptoms persist or worsen, consult your healthcare practitioner. Hypersensitivity/allergy, nausea, vomiting, and diarrhea have been known to occur, in which case discontinue use.

Safety-sealed for your protection and for product freshness. Do not use if outter seal is missing or broken.

Keep out of reach of children.

Additional Information

Code SC29-60

Store in a cool, dry place.

Pack Size:

Nutraceutical & Biophysical Systems

Seroyal

Metadata

Product Details

UPC / SKU883196 20401
DSLD Entry Date2016-01-25
Product TypeOther Combinations
FormCapsule
BrandPharmax
DSLD ID55647
Data Updated2026-04-11
Research

Research Evidence

33
Research Sources
55
Avg Quality
17
Systematic Review
12
Meta Analysis
3
Rct
1
Clinical Trial
A Oral herbal therapies for treating osteoarthritis
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis
Meta Analysis Seminars in arthritis and rheumatism 2018 PubMed DOI
B Evaluating the efficacy and safety of Curcuma longa, Boswellia serrata, and their mixed formulation in treating knee osteoarthritis: A systematic review and network meta-analysis
Systematic Review Complementary therapies in medicine 2026 PubMed DOI
B Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis
Meta Analysis BMC complementary medicine and therapies 2020 PubMed DOI
B Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis
Systematic Review Frontiers in pharmacology 2022 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
B Ayurvedic interventions for osteoarthritis: a systematic review and meta-analysis
Meta Analysis Rheumatology international 2015 PubMed DOI
B Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis
Meta Analysis Phytotherapy research : PTR 2017 PubMed DOI
B Frankincense: systematic review
Systematic Review BMJ (Clinical research ed.) 2008 PubMed DOI
View all evidence for Boswellia →
Compare

Similar Products

View all Boswellia products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.